LCHADD Retinopathy
from MitoAction Expert Series Hosted by MitoAction
The underlying cause of LCHADD retinopathy is not fully understood. This presentation will look at the research that identifies the cell in the eye that is initially affected and characteristics associated with vision loss. Join Dr. Gillingham as she discusses early data on the natural history study and some new pre-clinical models to test novel treatments for LCHADD retinopathy.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of MitoAction Expert Series?
This episode is 1 hour and 7 minutes long.
When was this MitoAction Expert Series episode published?
This episode was published on October 5, 2022.
Can I download this MitoAction Expert Series episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.